ArticleOncoimmunology

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML.

Anne-Sophie Chretien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.